Global Point of care Molecular Diagnostics Market Analysis & Trends 2016-2025 By Technology, Test Location, Application - Research and Markets
DUBLIN, Feb 17, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Point of care Molecular Diagnostics Market Analysis & Trends - Technology, Test Location, Application - Forecast to 2025" report to their offering.
Some of the prominent trends that the market is witnessing include rising investments in research and development increasing portfolio of Molecular POCT.
Based on Technology the Market is categorized into Microarray-based, Hybridization-based, PCR-based and Genetic Sequencing-based. Depending on the Test Location the market is segmented by POC (Point-of-care) and OTC (Over-the-counter).
Based on End User the Market is categorized into Hospitals, Assisted Living Healthcare Facilities, Decentralized Labs, Home-care and Other End Users. Depending on the Application the market is segmented by Endocrinology, Infectious Diseases, Prenatal Testing, Hematology, Oncology and Other Applications.
This industry report analyzes the global markets for Molecular Point of Care Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Rising investments in research and development
3.1.2 Increasing portfolio of Molecular POCT
3.1.3 Recent Technological advancements in Point of care Molecular Diagnostics
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Point of care Molecular Diagnostics Market, By Technology
4.1 Microarray-based
4.2 Hybridization-based
4.3 PCR-based
4.4 Genetic Sequencing-based
5 Point of care Molecular Diagnostics Market, By Test Location
5.1 POC(Point-of-care) )
5.2 OTC (Over-the-counter)
6 Point of care Molecular Diagnostics Market, By End User
6.1 Hospitals
6.2 Assisted Living Healthcare Facilities
6.3 Decentralized Labs
6.4 Home-care
6.5 Other End Users
7 Point of care Molecular Diagnostics Market, By Application
7.1 Endocrinology
7.2 Infectious Diseases
7.3 Prenatal Testing
7.4 Hematology
7.5 Oncology
7.6 Other Applications
8 Point of care Molecular Diagnostics Market, By Geography
9 Key Player Activities
9.1 Mergers & Acquisitions
9.2 Partnerships, Joint Venture's, Collaborations and Agreements
9.3 Product Launch & Expansions
9.4 Other Activities
10 Leading Companies
10.1 Roche Diagnostics
10.2 OraSure Technologies Inc.
10.3 Danaher Corporation
10.4 Dako
10.5 Bio-rad Laboratories
10.6 bioMerieux
10.7 Bayer Healthcare
10.8 Alere Inc (Abbott)
10.9 Abbott Laboratories
10.10 Abaxis Inc.
For more information about this report visit http://www.researchandmarkets.com/research/d7gv2m/global_point_of
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article